Signaling Pathways
Signal transduction pathways constitute a precisely regulated network through which cells perceive external stimuli and initiate intracellular responses. Core research in this field focuses on the mechanisms of molecular signal transmission and regulation within cells and typically encompasses three fundamental stages: signal initiation, signal propagation through cascades, and downstream effector responses. Key molecules—including proteins, nucleic acids, and small molecules—interact with high specificity and are subject to tight regulation (e.g., protein phosphorylation, molecular activation/inhibition). These processes underpin the full spectrum of cellular activities, including proliferation, differentiation, metabolism, apoptosis, and immune responses. While accurate regulation of these pathways is essential for maintaining organismal homeostasis, their dysregulation is a major driver of the onset and progression of diseases such as cancer, neurodegenerative disorders, and autoimmune diseases.
APExBIO is strongly committed to advancing life science research by providing a comprehensive portfolio of small-molecule tools designed to support the elucidation of signaling mechanisms and the identification of key regulatory targets—critical steps for deciphering disease etiology and developing innovative therapies. Our offerings span all major signal transduction pathways, including classical pathways (e.g., PI3K/Akt, MAPK, NF-κB), emerging modalities (e.g., ferroptosis, cuproptosis, pyroptosis), and research on pathway crosstalk. With tens of thousands of products—including inhibitors, activators, and modulators—we robustly support research in oncology, immunology, neuroscience, epigenetics, and other key fields.
Every APExBIO product undergoes rigorous functional validation and purity testing, ensuring suitability for diverse research applications such as pathway mechanism studies, target identification and validation, drug activity evaluation, cell-based assays, and animal model development. We complement our high-quality tools with comprehensive support: each product is supplied with detailed chemical property reports, biological activity data, standardized usage guidelines, and extensive literature citations in high-impact journals. In addition, we provide end-to-end assistance—from product selection and experimental protocol optimization to technical troubleshooting—enabling researchers to rely on tool quality, focus on core scientific questions, and accelerate progress in signal transduction research and translational medicine.
-
BA3360 Mcl1-IN-1Summary: Mcl1-IN-1 is a myeloid cytokine 1 inhibitor. -
BA3362 RK-9123016Summary: RK-9123016 is a potent inhibitor. -
BA3377 Ac-FLTD-CMKSummary: Ac-FLTD-CMK is an inhibitor derived from gephyrin D (GSDMD), a specific inhibitor of inflammation. -
BA3378 VRT-043198Summary: VRT-043198 is the active metabolite of VX-765 (Belnacasan), a potent, selective inhibitor that crosses the blood-brain barrier. -
BA3379 EF24Summary: EF24 is a curcumin analog with enhanced antitumor efficacy and oral bioavailability. -
BA3380 OT-82Summary: OT-82 is a potent, selective and orally active inhibitor. -
BA3381 MX1013Summary: MX1013 is a potent and irreversible dipeptide inhibitor with anti-apoptotic activity. -
BA3382 GDC-2394Summary: GDC-2394 is an orally effective and selective inhibitor. -
BA3383 PralnacasanSummary: Pralnacasan (VX-740) is a potent, selective, non-peptide-based, orally active interleukin 1β-converting enzyme inhibitor. -
BA3385 Beta-EudesmolSummary: Beta-Eudesmol has anti-cancer and anti-inflammatory activities.

